ContextA low plasma level of high-density lipoprotein cholesterol (HDL-C) is a major risk
factor for coronary heart disease (CHD). A secondary prevention study, the Veterans Affairs …

Background Decreased high-density lipoprotein (HDL) cholesterol levels constitute a major
risk factor for coronary heart disease; however, there are no therapies that substantially raise …

Background Maintenance of weight loss is a core problem in the treatment of obesity.
Physical activity may improve maintenance and metabolic risk factors associated with …

Background: Partially hydrogenated fat has an unfavorable effect on cardiovascular disease
risk. Palm oil is a potential substitute because of favorable physical characteristics …

Objective—We have previously reported that genetic variation at the cholesteryl ester
transfer protein (CETP) Taq IB locus is correlated with plasma lipid levels and coronary heart …

Background: A variety of soybean oils were developed with improved oxidative stability and
functional characteristics for use as alternatives to partially hydrogenated fat. Objective: The …

We compared the effects of five different statins (atorvastatin, simvastatin, pravastatin,
lovastatin, and fluvastatin) on the lipid, lipoprotein, and apolipoprotein (apo) AI-containing …

We investigated the effects of atorvastatin on the lipid and the apoA-I-containing HDL
subpopulation profiles in 86 patients with established coronary heart disease (CHD). The …

BACKGROUND: Several studies support the hypothesis that oxidation of low-density
lipoprotein (LDL) promotes atherogenesis. Obesity is one of the risk factors of …

Relative to saturated fatty acids, trans-fatty acids/hydrogenated fat-enriched diets have been
reported to increase low density lipoprotein (LDL) cholesterol levels and either decrease or …